**Core Concept**
Non-melanoma skin cancers, particularly squamous cell carcinoma (SCC), are known to be a significant concern in immunocompromised patients, such as renal transplant recipients. This is due to their impaired ability to mount an effective immune response against oncogenic viruses like human papillomavirus (HPV), which is a major risk factor for SCC.

**Why the Correct Answer is Right**
The increased risk of skin cancers in renal transplant recipients is largely attributed to the suppression of their immune system by immunosuppressive medications, such as cyclosporine and tacrolimus. These medications reduce the body's ability to recognize and eliminate cancer cells. Furthermore, the presence of oncogenic viruses like HPV in the environment can lead to the development of SCC in these vulnerable patients. The skin is the most common site of cancer development in renal transplant recipients.

**Why Each Wrong Option is Incorrect**
**Option A:** Kaposi's sarcoma is another cancer that can occur in immunocompromised patients, but it is not the most common type of cancer in renal transplant recipients.
**Option B:** Renal cell carcinoma is a type of kidney cancer that can occur in the general population, but it is not specifically associated with renal transplantation.
**Option C:** Lymphoma is a type of blood cancer that can occur in immunocompromised patients, but it is not the most common type of cancer in renal transplant recipients.

**Clinical Pearl / High-Yield Fact**
Immunosuppressed patients, including renal transplant recipients, are at increased risk of developing skin cancers, particularly SCC. Regular skin examinations and sun protection measures are essential in these patients to prevent and detect skin cancers early.

**Correct Answer: D. Squamous cell carcinoma**